NEWS
- 2023/04/19
- Number of Companies Using alt Inc.’s AI GIJIROKU Surpasses 6,000
- 2023/04/14
- alt Inc. to Host alt Conference 2023 –“Life or Death : The Destruction and Creation of Generative AI ”– on Wednesday, May 24, from 3:00 to 6:30 p.m.
How will the world change with the development of generative AI? Hear the latest research from a variety of AI leaders!
- 2023/04/13
- AI GIJIROKU Equipped with AI Assistant function to Automatically Extract Important Points, To-Dos, Conclusions, and Agreements
Makes the automatic creation of meeting minutes even easier to improve operational efficiency
- 2023/04/06
- Achievement in Japan’s National Medical Examination Generative AI Jointly Developed by alt Inc. and Fast Doctor Reaches Passing Score in National Medical Examination
Including Contraindication Questions
- 2023/04/04
- alt Inc. begins collaboration with BIZTEL, Japan's Top Share Cloud-based Call Center System
AI will help optimize corporate performance by enabling the widespread use of voice bots that automatically answer phone calls
- 2023/03/30
- alt Inc., Masterpiece, and Comdesign jointly develop large-scale language processing model LHTM-2 call center version
Next-generation automatic FAQ generation and response functionality implemented in AI-BPO Double BRAIN
- 2023/03/28
- alt Inc. Launches AI GIJIROKU 100 for Human Correction of Automatically Generated Transcripts
Achieves 100% accuracy in creating minutes by directly requesting corrections and sentence alignment
- 2023/03/08
- alt Inc. releases two additional free white papers on next-generation voicebot AI Call Center
The white papers provide success stories of overseas voicebot use and cost reduction
- 2023/03/07
- alt Inc. announces strengthening of business headquarters
Accelerating solutions to clients' issues and the social implementation of AI
- 2023/03/06
- alt Inc. collaborates with AI, Inc., a developer and provider of speech synthesis technology
The project is a demo for service provision using alt's large-scale language processing model LHTM-2 and ChatGPT
